Strategic collaborations are key to improving the pace and access to research. Undiagnosed and Overlooked Everyone knows someone impacted by Alzheimer’s disease, as it affects an estimated 55 million people worldwide. What is often overlooked is the shocking number of people who remain undiagnosed due to fear of going to a doctor, lack of access […]
For the first time in 15 years, there are new Alzheimer’s drug treatments on the horizon that are expected to seek regulatory approval by the FDA and leading experts are increasely optimistic that a major breakthrough in Alzheimer’s research will occur within the next five years. We are at a moment of peak opportunity – […]
It’s fitting that November is National Alzheimer’s Disease Awareness Month and National Family Caregivers Month. Nearly half of all caregivers for older adults in the United States – family, friends and other unpaid caregivers – are caring for someone with Alzheimer’s disease (AD). Caregivers are essential to those living with Alzheimer’s and contribute 18.5 […]
The facts are staggering… every 65 seconds someone in the United States develops Alzheimer’s disease. It is the most expensive disease in America, with the total direct cost of treatment approaching $300 billion annually – greater than for cancer or heart disease. It is the only leading cause of death in the US that cannot […]
The fight against a global epidemic September is a key month in the fight against Alzheimer’s and other dementias. Driven by Alzheimer’s Disease International, September has been designated as World Alzheimer’s Month with World Alzheimer’s Day on September 21 to prompt organizations worldwide to raise awareness and challenge the stigma that surround dementia. Global efforts are […]